Arterial spin labelling reveals prolonged arterial arrival time in idiopathic Parkinson's disease

Sarah Al-Bachari1, Laura M Parkes2, Rishma Vidyasagar2

  • 1Department of Neurology, Royal Preston Hospital, Preston, UK ; Centre for Imaging Science, Institute of Population Health, University of Manchester, UK.

Neuroimage. Clinical
|November 8, 2014
PubMed

Keywords:
3T, 3 TeslaAAT, arterial arrival timeAD, Alzheimer’s diseaseASL, arterial spin labellingArterial arrival timeArterial spin labellingCBF, cerebral blood flowCO2, carbon dioxideCV, cerebrovascularCVD, cerebrovascular diseaseCVR, cerebrovascular reactivityCVRAAT, cerebrovascular reactivity measures of arterial arrival timeCVRCBF, cerebrovascular reactivity measures of cerebral blood flowCerebral blood flowCerebrovascular reactivityDS, digit spanDSST, digit symbol substitution testDWMH, deep white matter hyperintensityEPI, echo planar imagingETCO2, end-tidal carbon dioxideFAS, (verbal) fluency assessment scaleFLAIR, fluid attenuation inversion recoveryFWE, family-wise errorHAM-D, Hamilton depression rating scaleIPD, idiopathic Parkinson's diseaseIdiopathic Parkinson's diseaseL-dopa, levodopaLARS, Lille apathy rating scaleLEDD, levodopa equivalent daily doseMCI, mild cognitive impairmentMRI, magnetic resonance imagingMoCAMoCA, Montreal cognitive assessmentNPI, neuropsychiatric inventoryNVU, Neurovascular unitO2−, oxygenPET, positron emission tomographyPIGD, Postural instability and gait disorderPL, parietal lobePVH, periventricular hyperintensityROI, region of interestSPECT, single positron emission computed tomographySPM, statistical parametric mappingSTAR, signal targeting with alternating radiofrequencyTD, tremor dominantTE, echo timeTI, inversion timeTL, temporal lobeTMT-B, trail making test BTR, repetition timeUKPDS BB, United Kingdom Parkinson's Disease Society Brain BankUPDRS, Unified Parkinson's disease Rating ScaleWAIS-R, Wechsler adult intelligence scale-revisedWML, white matter lesionfMRI, functional magnetic resonance imaging

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
11
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
5
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
729
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.5K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K